Sato, Takahiro published the artcileDiscovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 – a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia. [Erratum to document cited in CA152:037497], Application In Synthesis of 135048-32-7, the publication is Bioorganic & Medicinal Chemistry Letters (2010), 20(7), 2390, database is CAplus.
The title should read: “Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 – a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia”. The compound name needs to be corrected throughout the article. On page 6225, the chem. name for Compound 2 is incorrect and should read: ‘2-[2-(2-methoxyethoxy)ethoxy]-5-[5-(2-methyl-4-pyridyl)-1H-[1,2,4]triazol-3-yl]benzonitrile. On page 6225, the chem. name for compound 39 should read: ‘3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole. On page 6228, the compound in line 25 should read: “2-methyl-4-pyridyltriazole”.
Bioorganic & Medicinal Chemistry Letters published new progress about 135048-32-7. 135048-32-7 belongs to nitriles-buliding-blocks, auxiliary class Pyridine,Nitrile,Hydrazine,Amine,Hydrazide,Amide, name is 2-Cyanoisonicotinohydrazide, and the molecular formula is C7H6N4O, Application In Synthesis of 135048-32-7.
Referemce:
https://en.wikipedia.org/wiki/Nitrile,
Nitriles – Chemistry LibreTexts